Ignite Creation Date:
2024-05-06 @ 8:20 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02717702
Status:
COMPLETED
Last Update Posted:
2019-08-19
First Post:
2016-03-18
Brief Title:
Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
Abbott Stress-Delta Biomarkers for ACS Risk Stratification
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Acute Coronary Syndrome ACS is a serious heart condition that is a leading cause of death in America Cardiac stress testing is currently the best test to non-invasively identify which patients might be having ACS and may need more invasive testing such as a cardiac catheterization placing a tube in the heart for coronary angiogram invasive mapping of the blood vessels of the heart However stress tests require imaging by highly trained specialists and even then may not correctly categorize a small minority of patients being evaluated for ACS
Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test The investigators seek to determine whether these blood tests can help to better identify patients with ACS The study will also store any extra blood sample that may be left over for future use
Advances in blood tests may now allow detection of the very early stages of heart blood vessel blockage via a simple blood test The investigators seek to determine whether these blood tests can help to better identify patients with ACS The study will also store any extra blood sample that may be left over for future use
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None